https://www.ithera-medical.com/wp-content/uploads/2021/01/iThera-Startanimation-201218-final-1-1.mp4#t=10,70 How can optoacoustic imaging benefit you? Due to its spatiotemporal resolution, penetration depth, sensitivity and specificity, optoacoustic imaging (OAI) can be used for a multitude of applications, for both preclinical and clinical research: Preclinical research In the past 5-10 years, OAI has become an established imaging modality for in vivo preclinical research. Based on its unique […]
Location: Germany, Bavaria, Munich
Total raised: $13.8M
Founded date: 2010
Investors 4
| Date | Name | Website |
| - | OCCIDENT | occident.g... |
| - | BayBG | baybg.de |
| - | BayBG Vent... | baybg-vc.d... |
| - | Fluxunit -... | fluxunit.d... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 22.12.2022 | - | $13.8M | - |
Mentions in press and media 11
| Date | Title | Description |
| 22.12.2022 | iThera Medical Closes €13M Financing | iThera Medical, a Munich, Germany-based medical device company that develops and markets optoacoustic imaging systems for preclinical and clinical research, closed a €13M funding round. The round was led by TRUMPF Venture with participation... |
| 21.12.2022 | iThera Medical closes €13 Million financing to fund translation of their optoacoustic imaging technology into routine clinical use | MUNICH (PRWEB) December 21, 2022 In clinical practice, a wide range of diagnostic procedures are essential for clinicians to diagnose disease and monitor treatment response. However, many fields have an unmet need for accurate, objective, a... |
| 21.06.2022 | iThera Medical reports initiation of fifth clinical site in ongoing study for the non-invasive assessment of inflammatory bowel disease | MUNICH, Germany (PRWEB) June 21, 2022 IBD is a chronic condition marked by recurring phases of inflammation and remission of the gastrointestinal tract. For many patients, adequate treatment can help to effectively manage the symptoms of th... |
| 20.05.2022 | iThera Medical Leads €1.6 Million Project to Develop Novel Machine Learning-assisted Optoacoustic Imaging of Neuromuscular Disease | Duchenne muscular dystrophy (DMD) is a rare genetic disease that presents as progressive muscle degeneration. Patients with DMD face an extremely hard battle; symptoms of the disease frequently become life-threatening, and no known cures ex... |
| 17.05.2022 | iThera Medical leads €1.6m project to develop novel machine learning-assisted optoacoustic imaging of neuromuscular disease | MUNICH, Germany (PRWEB) May 17, 2022 Duchenne muscular dystrophy (DMD) is a rare genetic disease that presents as progressive muscle degeneration. Patients with DMD face an extremely hard battle; symptoms of the disease frequently become li... |
| 15.10.2021 | iThera Medical awarded major European grant to translate its optoacoustic imaging technology from research to routine clinical use | ...we believe it will be a game-changer for millions of patients worldwide. MUNICH (PRWEB) October 15, 2021 Within medical diagnostics, a wide range of procedures allows clinicians to diagnose diseases and monitor treatment response. Howeve... |
| 23.09.2021 | iThera Medical reports initiation of second site in ongoing clinical study for the non-invasive assessment of inflammatory bowel disease | We are excited to be part of this groundbreaking clinical study, which will assess a very promising and non-invasive new technology for IBD inflammatory status monitoring. MUNICH (PRWEB) September 23, 2021 The chronic condition IBD is marke... |
| 13.09.2021 | iThera Medical leads €1.9m research project to advance optoacoustic imaging technology towards AI-supported quantitative medical diagnosis | We are extremely excited to lift clinical diagnostics to a new level through the introduction of groundbreaking AI technology in an MSOT device. This will make the technology applicable to a wider patient population. MUNICH, Germany (PRWEB)... |
| 25.05.2021 | CE Mark awarded to iThera Medical’s second-generation MSOT Acuity Echo optoacoustic imaging system | With the imminent introduction of the strict MDR regulations adding complexity to the life of clinical researchers, users can now rely on a CE-marked device for their clinical trials MUNICH, Germany (PRWEB) May 25, 2021 “We are very excited... |
| 23.11.2011 | iThera Medical Closes Series A Funding | iThera Medical, a Munich Germany-based company that develops and markets a novel in-vivo biomedical imaging technology, recently closed a Series A funding round of undisclosed amount. Backers include BayBG Bayerische Beteiligungsgesellschaf... |
Show more